HLA-C and neoplasm: TDSEVs that carry antigens or antigen MHC complexes may directly transfer these components to antigen presenting cells, increasing the ability of displaying TDSEV-derived tumor antigens on their MHC-I/CD8 or MHC-II/CD4 complexes, and thus controlling tumor-mediated T cell responses [115].